Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study
Table 2
Onset and pathogens isolated from surgical site infections (SSIs) after hyperthermic intraperitoneal chemotherapy (HIPEC) operation.
Superficial
Deep
Pathogen
Number
Time (day)
Pathogen
Number
Time (day)
Bacterial isolate
12 (27%)
9 (20%)
Gram-positive organisms
Enterococcus faecium (VRE)
3 (1)
16 ± 9.5
Enterococcus faecium (VRE)
2 (1)
14.5 ± 17.68
Gram-negative organisms
Pseudomonas aeruginosa
1
34
Escherichia coli (ESBL)
5
10 ± 10.07
Escherichia coli (ESBL)
1
2
Escherichia coli
2
17 ± 21.21
Escherichia coli
1
5
Proteus vulgaris
2
24 ± 19.8
Acinetobacter baumannii (MDRO)
3
24 ± 12.29
Klebsiella pneumoniae (ESBL)
1
19
Gram-positive/Gram-negative ratio
1/3
0.24
Fungal isolate
2 (4%)
2 (4%)
Candida albicans
1
25
Candida albicans
1
32
YOTCA
1
58
YOTCA
1
39
VRE, vancomycin-resistant enterococci; ESBL, extended-spectrum beta-lactamase; MDRO, multidrug-resistant organisms; YOTCA, yeasts other than Candida albicans.
